Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-000218
Filing Date
2024-03-18
Accepted
2024-03-18 06:50:36
Documents
83
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lptx-20231231x10k.htm   iXBRL 10-K 1894951
2 EX-10.33 lptx-20231231xex10d33.htm EX-10.33 5210
3 EX-21.1 lptx-20231231xex21d1.htm EX-21.1 9900
4 EX-23.1 lptx-20231231xex23d1.htm EX-23.1 5345
5 EX-31.1 lptx-20231231xex31d1.htm EX-31.1 15666
6 EX-32.1 lptx-20231231xex32d1.htm EX-32.1 10484
7 EX-97.1 lptx-20231231xex97d1.htm EX-97.1 47418
  Complete submission text file 0001410578-24-000218.txt   8068495

Data Files

Seq Description Document Type Size
8 EX-101.SCH lptx-20231231.xsd EX-101.SCH 58882
9 EX-101.CAL lptx-20231231_cal.xml EX-101.CAL 55382
10 EX-101.DEF lptx-20231231_def.xml EX-101.DEF 209791
11 EX-101.LAB lptx-20231231_lab.xml EX-101.LAB 545253
12 EX-101.PRE lptx-20231231_pre.xml EX-101.PRE 389787
87 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20231231x10k_htm.xml XML 1258223
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37990 | Film No.: 24756881
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)